Newsletter | October 30, 2026

10.30.26 -- The New Clinical Trial Regulatory Landscape Balances Speed, Quality, And Compliance — Are You Ready?

SPONSOR

Webinar: From Black Box to Trusted Tool: How One Site Verified AI

AI can transform clinical research workflows, but in high-stakes environments, trust can’t be automated. Luke Snedaker of West Clinical Research and Mike Wenger of CRIO share what they learned building AI-powered eSource workflows, from early missteps to combining AI with deterministic code and safeguards. Discover a practical framework for deciding where AI belongs and how to use it. Click here to learn more.

CLINICAL DATA MANAGEMENT & ANALYTICS

EHR-To-EDC Needs A Reality Check

Rebecca Jackson offers a candid reality check on EHR-to-EDC integration, AI, and clinical trial technology, arguing that innovation must solve real operational problems — not create new ones.

Proving CNS Target Engagement With Neuroimaging

The key question is not whether a scan changes, but what link in the dose-to-effect chain it resolves. Combining PET, MRI, PK/PD, and functional measures reduces uncertainty.

Data Quality And How It Impacts Clinical Trials

Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.

The Future Of Clinical Trials: AI, Real-Time Data, And FDA Innovation

How does building trial protocols into health records lets key safety and efficacy signals reach sponsors and regulators in days, cutting manual data entry and speeding decisions.

Live AI Demonstration: 15 Minutes. From Nothing To Validation-Ready

Transform a blank slate into a validation-ready clinical study in as little as 10 to 15 minutes.

TRIAL MONITORING

The New Clinical Trial Regulatory Landscape Balances Speed, Quality, And Compliance — Are You Ready?

Part one of this two-part series explores how clinical trial regulation aims to balance speed, quality, compliance, and digital innovation.

Early QT/TQT Studies

Early Precision QT studies at a Clario-certified Phase I unit can help sponsors collect high-quality cardiac safety data earlier and potentially waive costly Thorough QT studies.

Connect With Clinical Leader: